U.S. Incidence of Distant-Stage Prostate Cancer Up, 2010 to 2017
Five-year survival for distant-stage prostate cancer improved from 2011 to 2016.
Five-year survival for distant-stage prostate cancer improved from 2011 to 2016.
Two studies show decreases in incidence and death rates, but variation by sex, race/ethnicity, age.
Increases seen across the U.S., in men and women, in whites and blacks, for colon and rectal cancers.
Overall cancer mortality and mortality for liver, esophageal, pancreatic cancer up with severe psoriasis.
Higher rates reported for lung, liver, kidney, colorectal, and stomach cancers versus whites.
Despite overall decline or stabilization, increase seen for young adults in some high-income countries.
From 1999 to 2015, overall cancer death rates decreased by 1.8 and 1.4 percent per year among men and women, respectively.
A retrospective review of data from the National Cancer Data Base demonstrated that trends in rectal cancer may follow a pattern similar to that of colon cancer.
Researchers observed a decrease in the age-specific incidence of lung cancer among both men and women aged 30 to 54 years over the past two decades; the declines among men were steeper.
Hypogonadal men who received testosterone replacement therapy had a lower incidence of prostate cancer than those who did not, and their cancers were less severe.